COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells

被引：0
|
作者：
Naoise C. Synnott
David O’Connell
John Crown
Michael J. Duffy
机构：
[1] University College Dublin,UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research
[2] University College Dublin,UCD School of Biomolecular & Biomedical Science
[3] St. Vincent’s University Hospital,Department of Medical Oncology
[4] St. Vincent’s University Hospital,UCD Clinical Research Centre
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
p53; TP53; COTI-2; Triple-negative breast cancer; Treatment; APR-246;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [41] Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
    Purwanto, Ibnu
    Leo, Benedreky
    Hutajulu, Susanna Hilda
    Kurnianda, Johan
    Taroeno-Hariadi, Kartika Widayati
    Hardianti, Mardiah Suci
    Satiti, Amanda Dania
    Dwianingsih, Ery Kus
    Heriyanto, Didik Setyo
    Widodo, Irianiwati
    Aryandono, Teguh
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 515 - 524
  • [42] Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo
    Li, Hong-chang
    Xia, Zhi-hua
    Chen, Ya-feng
    Yang, Fan
    Feng, Wen
    Cai, Han
    Mei, Yi
    Jiang, Yi-ming
    Xu, Ke
    Feng, Dian-xu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 43 (05) : 1829 - 1840
  • [43] Elaeagnus angustifolia Plant Extract Induces Apoptosis via P53 and Signal Transducer and Activator of Transcription 3 Signaling Pathways in Triple-Negative Breast Cancer Cells
    Fouzat, Arij
    Hussein, Ola Jihad
    Gupta, Ishita
    Al-Farsi, Halema F.
    Khalil, Ashraf
    Al Moustafa, Ala-Eddin
    FRONTIERS IN NUTRITION, 2022, 9
  • [44] Imipramine Induces Apoptosis and Inhibits the Metastatic Potential of Triple-negative Breast Cancer Cells
    Chen, Sheng-Kai
    Lee, Wei
    Li, Yu-Ching
    Hsu, Fei-Ting
    Chen, Wei-Ting
    ANTICANCER RESEARCH, 2023, 43 (07) : 2985 - 2994
  • [45] Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
    Li, Jing-ping
    Zhang, Xiang-mei
    Zhang, Zhenzhen
    Zheng, Li-hua
    Jindal, Sonali
    Liu, Yun-jiang
    MEDICINE, 2019, 98 (18)
  • [46] RB1 and p53 at the crossroad of EMT and triple negative breast cancer
    Jiang, Zhe
    Jones, Robert
    Liu, Jeff C.
    Deng, Tao
    Robinson, Tyler
    Chung, Philip E. D.
    Wang, Sharon
    Herschkowitz, Jason I.
    Egan, Sean E.
    Perou, Charles M.
    Zacksenhaus, Eldad
    CELL CYCLE, 2011, 10 (10) : 1563 - 1570
  • [47] Mutant p53 reactivators protect breast cancer cells from ferroptosis
    Rathnayake, Dewmi Sandaru
    Dlamini, Samkeliso
    Elkalawozgy, Kadry
    Tillekeratne, L. M. Viranga
    Taylor, William R.
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (04)
  • [48] Reverse engineering of triple-negative breast cancer cells for targeted treatment
    Bluemel, Lena
    von Wahlde, Marie-Kristin
    Tio, Joke
    Kiesel, Ludwig
    Bernemann, Christof
    MATURITAS, 2018, 108 : 24 - 30
  • [49] OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer
    Ding, Xiaorong
    Li, Yumei
    Li, Jun
    Yin, Yongmei
    CANCER MEDICINE, 2020, 9 (15): : 5558 - 5569
  • [50] LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
    Li, Yang
    Ma, Hong-Yu
    Hu, Xiao-Wei
    Qu, Yuan-Yuan
    Wen, Xin
    Zhang, Yu
    Xu, Qing-Yong
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
12345